# Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders

> **NCT03899285** · PHASE2 · COMPLETED · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 8 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Citalopram 20mg or 40 mg (phase 2)

## Key facts

- **NCT ID:** NCT03899285
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-08
- **Primary completion:** 2018-12-08
- **Final completion:** 2018-12-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899285, "Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT03899285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*